Skip to main content

Intersect ENT, Inc.

XENTDelisted May 13, 2022
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001271214

Intersect ENT, Inc. was delisted on May 13, 2022; its insiders filed their last Form 4 on May 16, 2022; 131 institutions reported holding it in 13F filings for Q1 2022, worth $828.8M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Intersect ENT, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of XENT: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders108107−1
Shares29.3M29.0M−272.6K (−0.9%)
Value$611.0M$495.5M−$115.4M (−18.9%)

New holders (11)

Institutions that held Intersect ENT, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to XENT in Q2 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC133,071$2.27M0.00%
Marshall Wace, LLP30,076$514.0K0.00%
Susquehanna International Group, LLP25,540$436.0K0.00%
Caption Management, LLC25,000$428.0K0.04%
Dynamic Technology Lab Private Ltd21,023$359.0K0.04%
Susquehanna Fundamental Investments, LLC20,846$356.0K0.01%
ExodusPoint Capital Management, LP18,440$315.0K0.00%
Trexquant Investment LP13,296$227.0K0.02%
Cinctive Capital Management LP12,000$205.0K0.01%
Group One Trading, L.P.5,151$88.0K0.00%
Farmers & Merchants Investments Inc47$1.00K0.00%

Sold out (12)

Institutions that held Intersect ENT, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.